The Use of Extracorporeal Membrane Oxygenation for COVID-19: Lessons Learned

Link to article at PubMed

Clin Chest Med. 2023 Jun;44(2):335-346. doi: 10.1016/j.ccm.2022.11.016. Epub 2022 Nov 29.


The coronavirus disease 2019 (COVID-19) pandemic has seen an increase in global cases of severe acute respiratory distress syndrome (ARDS), with a concomitant increased demand for extracorporeal membrane oxygenation (ECMO). Outcomes of patients with severe ARDS due to COVID-19 infection receiving ECMO support are evolving. The need for surge capacity, practical and ethical limitations on implementing ECMO, and the prolonged duration of ECMO support in patients with COVID-19-related ARDS has revealed limitations in organization and resource utilization. Coordination of efforts at multiple levels, from research to implementation, resulted in numerous innovations in the delivery of ECMO.

PMID:37085223 | PMC:PMC9705197 | DOI:10.1016/j.ccm.2022.11.016

Leave a Reply

Your email address will not be published. Required fields are marked *